Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis
Author:
Affiliation:
1. Department of Research & Development, Clinical PK CV, Bayer AG, Wuppertal, Germany.
2. Department of Clinical Operations, Inamed GmbH, Gauting, Germany.
3. Chrestos Concept GmbH & Co. KG, Essen, Germany.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine
Link
https://www.liebertpub.com/doi/pdf/10.1089/jamp.2018.1464
Reference13 articles.
1. Technological and practical challenges of dry powder inhalers and formulations
2. Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device
3. Effect of Dry Powder Inhaler Resistance on the Inspiratory Flow Rates and Volumes of Cystic Fibrosis Patients of Six Years and Older
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review;Journal of Clinical Medicine;2023-05-20
2. Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?;Frontiers in Drug Delivery;2022-03-22
3. Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery;Pharmaceutical Development and Technology;2021-05-05
4. Nuevos antibióticos inhalados y formas de administración;Open Respiratory Archives;2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3